IDH1 and central nervous system cancer: In contrast, patients >55 years old who have grade 4 gliomas that test negative for the IDH1 R132H mutation can be assumed also to be wildtype for the less common IDH variants and declared to have IDH-wildtype glioblastoma WHO grade 4.